SEC24C deficiency causes trafficking and glycosylation abnormalities in an epileptic encephalopathy with cataracts and dyserythropoeisis

SEC24C 缺乏症会导致癫痫性脑病伴白内障和红细胞生成障碍,并引起转运和糖基化异常。

阅读:2
作者:Nina Bögershausen ,Büsranur Cavdarli ,Taylor H Nagai ,Miroslav P Milev ,Alexander Wolff ,Mahsa Mehranfar ,Julia Schmidt ,Dharmendra Choudhary ,Óscar Gutiérrez-Gutiérrez ,Lukas Cyganek ,Djenann Saint-Dic ,Arne Zibat ,Karl Köhrer ,Tassilo E Wollenweber ,Dagmar Wieczorek ,Janine Altmüller ,Tatiana Borodina ,Dilek Kaçar ,Göknur Haliloğlu ,Yun Li ,Christian Thiel ,Michael Sacher ,Ela W Knapik ,Gökhan Yigit ,Bernd Wollnik
As a major component of intracellular trafficking, the coat protein complex II (COPII) is indispensable for cellular function during embryonic development and throughout life. The 4 SEC24 proteins (A-D) are essential COPII components involved in cargo selection and packaging. A human disorder corresponding to alterations of SEC24 function is currently known only for SEC24D. Here, we reported that biallelic loss of SEC24C leads to a syndrome characterized by primary microcephaly, brain anomalies, epilepsy, hearing loss, liver dysfunction, anemia, and cataracts in an extended consanguineous family with 4 affected individuals. We showed that knockout of sec24C in zebrafish recapitulated important aspects of the human phenotype. SEC24C-deficient fibroblasts displayed alterations in the expression of several COPII components as well as impaired anterograde trafficking to the Golgi, indicating a severe impact on COPII function. Transcriptome analysis revealed that SEC24C deficiency also affected the proteasome and autophagy pathways. Moreover, a shift in the N-glycosylation pattern and deregulation of the N-glycosylation pathway suggested a possible secondary alteration of protein glycosylation, linking the described disorder with the congenital disorders of glycosylation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。